Nevro ROE 2013-2023 | NVRO

Current and historical return on equity (ROE) values for Nevro (NVRO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Nevro ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2023-09-30 $-0.10B $0.29B -33.83%
2023-06-30 $0.00B $0.30B 0.96%
2023-03-31 $0.00B $0.30B 1.02%
2022-12-31 $0.00B $0.32B 1.43%
2022-09-30 $-0.01B $0.33B -2.55%
2022-06-30 $-0.14B $0.23B -50.87%
2022-03-31 $-0.14B $0.24B -44.55%
2021-12-31 $-0.13B $0.30B -39.20%
2021-09-30 $-0.11B $0.32B -30.47%
2021-06-30 $-0.07B $0.36B -18.50%
2021-03-31 $-0.09B $0.37B -23.34%
2020-12-31 $-0.08B $0.39B -24.47%
2020-09-30 $-0.09B $0.38B -30.38%
2020-06-30 $-0.10B $0.37B -39.08%
2020-03-31 $-0.09B $0.22B -40.91%
2019-12-31 $-0.10B $0.22B -50.12%
2019-09-30 $-0.10B $0.20B -46.57%
2019-06-30 $-0.09B $0.20B -41.10%
2019-03-31 $-0.08B $0.21B -32.03%
2018-12-31 $-0.05B $0.25B -20.45%
2018-09-30 $-0.04B $0.24B -17.92%
2018-06-30 $-0.04B $0.25B -15.89%
2018-03-31 $-0.04B $0.24B -16.38%
2017-12-31 $-0.04B $0.25B -15.15%
2017-09-30 $-0.04B $0.24B -17.60%
2017-06-30 $-0.04B $0.24B -16.72%
2017-03-31 $-0.04B $0.24B -15.42%
2016-12-31 $-0.03B $0.25B -13.17%
2016-09-30 $-0.04B $0.25B -15.03%
2016-06-30 $-0.05B $0.25B -21.38%
2016-03-31 $-0.06B $0.23B -25.57%
2015-12-31 $-0.07B $0.24B -29.78%
2015-09-30 $-0.06B $0.24B -29.15%
2015-06-30 $-0.05B $0.26B -31.25%
2015-03-31 $-0.04B $0.16B -39.15%
2014-12-31 $-0.03B $0.17B -54.79%
2014-06-30 $-0.02B $0.00B inf%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.518B $0.425B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $219.762B 26.76
Intuitive Surgical (ISRG) United States $140.191B 88.03
Edwards Lifesciences (EW) United States $51.243B 33.95
IDEXX Laboratories (IDXX) United States $47.932B 57.29
DexCom (DXCM) United States $46.933B 80.62
IQVIA Holdings (IQV) United States $45.949B 27.17
Alcon (ALC) Switzerland $42.771B 31.54
STERIS (STE) Ireland $23.001B 27.22
Waters (WAT) United States $20.487B 29.45
SONOVA HOLDING (SONVY) Switzerland $18.657B 0.00
Hologic (HOLX) United States $17.288B 19.08
Sysmex ADR (SSMXY) Japan $11.750B 36.86
Fresenius Medical Care AG KGaA (FMS) Germany $11.361B 14.03
Teleflex (TFX) United States $10.493B 16.49
ShockWave Medical (SWAV) United States $9.851B 68.06
Penumbra (PEN) United States $9.160B 113.24
Globus Medical (GMED) United States $7.371B 23.37
Masimo (MASI) United States $6.693B 37.53
Glaukos (GKOS) United States $4.394B 0.00
Integer Holdings (ITGR) United States $3.725B 23.88
LivaNova (LIVN) United Kingdom $2.976B 19.66
Elekta AB (EKTAY) Sweden $2.884B 19.79
Integra LifeSciences Holdings (IART) United States $2.815B 11.61
TransMedics (TMDX) United States $2.706B 0.00
Inari Medical (NARI) United States $2.615B 454.00
PROCEPT BioRobotics (PRCT) United States $2.500B 0.00
Nihon Kohden (NHNKY) Japan $2.446B 20.69
RxSight (RXST) United States $2.060B 0.00
Alphatec Holdings (ATEC) United States $1.852B 0.00
Tandem Diabetes Care (TNDM) United States $1.810B 0.00
Veracyte (VCYT) United States $1.753B 0.00
Pacific Biosciences Of California (PACB) United States $1.391B 0.00
Paragon 28 (FNA) United States $0.973B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.867B 16.03
Treace Medical Concepts (TMCI) United States $0.829B 0.00
Artivion (AORT) United States $0.784B 90.57
OPKO Health (OPK) United States $0.768B 0.00
SiBone (SIBN) United States $0.701B 0.00
Silk Road Medical (SILK) United States $0.673B 0.00
OrthoPediatrics (KIDS) United States $0.656B 0.00
Mesa Laboratories (MLAB) United States $0.590B 20.04
Pulse Biosciences (PLSE) United States $0.566B 0.00
IRadimed (IRMD) United States $0.532B 31.03
ORTHOFIX MEDICAL INC (OFIX) United States $0.478B 0.00
AxoGen (AXGN) United States $0.460B 0.00
CVRx (CVRX) United States $0.435B 0.00
NeuroPace (NPCE) United States $0.420B 0.00
Tactile Systems Technology (TCMD) United States $0.362B 12.28
Semler Scientific (SMLR) United States $0.326B 19.00
Accuray (ARAY) United States $0.259B 0.00
EDAP TMS S.A (EDAP) France $0.251B 0.00
908 Devices (MASS) United States $0.238B 0.00
AngioDynamics (ANGO) United States $0.219B 0.00
Alpha Tau Medical (DRTS) Israel $0.208B 0.00
Sight Sciences (SGHT) United States $0.200B 0.00
ClearPoint Neuro (CLPT) United States $0.165B 0.00
Inogen (INGN) United States $0.164B 0.00
Atossa Genetics (ATOS) United States $0.125B 0.00
Envoy Medical (COCH) United States $0.122B 0.00
Spectral Diagnostics (EDTXF) Canada $0.115B 0.00
KORU Medical Systems (KRMD) United States $0.096B 0.00
Delcath Systems (DCTH) United States $0.092B 0.00
Neuronetics (STIM) United States $0.087B 0.00
EnVVeno Medical (NVNO) United States $0.086B 0.00
Monogram Orthopaedics (MGRM) United States $0.081B 0.00
Hyperfine (HYPR) United States $0.079B 0.00
Autonomix Medical (AMIX) $0.075B 0.00
Sensus Healthcare (SRTS) United States $0.068B 137.67
Vicarious Surgical (RBOT) United States $0.064B 0.00
SEP Acquisition (SEPA) United States $0.063B 0.00
Yubo Biotech (YBGJ) China $0.061B 0.00
InspireMD (NSPR) Israel $0.057B 0.00
ReWalk Robotics (LFWD) Israel $0.057B 0.00
Lucid Diagnostics (LUCD) United States $0.055B 0.00
DarioHealth (DRIO) United States $0.054B 0.00
Vasomedical (VASO) United States $0.053B 4.07
LENSAR (LNSR) United States $0.053B 0.00
Pixie Dust Technologies (PXDT) Japan $0.045B 0.00
Rapid Micro Biosystems (RPID) United States $0.042B 0.00
Aspira Women's Health (AWH) United States $0.041B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Spectral AI (MDAI) United States $0.033B 0.00
Ekso Bionics Holdings (EKSO) United States $0.030B 0.00
PAVmed (PAVM) United States $0.022B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.021B 0.00
PetVivo Holdings (PETV) United States $0.018B 0.00
T2 Biosystems (TTOO) United States $0.018B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Accelerate Diagnostics (AXDX) United States $0.014B 0.00
NexGel (NXGL) United States $0.014B 0.00
ENDRA Life Sciences (NDRA) United States $0.012B 0.00
Check-Cap (CHEK) Israel $0.012B 0.00
Biosig Technologies (BSGM) United States $0.006B 0.00
Avinger (AVGR) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00